Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?

International Journal of Nephrology and Renovascular Disease

Volumn 6, Issue , 2013, Pages 71-77

  Tutal, Emre ^a   Sayin, Burak ^a   Ertugrul, Derun Taner ^b   Ibis, Avsin ^a   Sezer, Siren ^a   Özdemir, Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Kecioren Research and Training Hospital   (Turkey)

Author keywords

Hypertension; Non dipper; Uric acid

Indexed keywords

CREATININE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; URIC ACID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HIP CIRCUMFERENCE; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORNING BLOOD PRESSURE SURGE; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84876975396     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S41384     Document Type: Article

References (34)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specifc relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
2. Kario K, Schwartz JE, Gerin W, Robayo N, Maceo E, Pickering TG. Psychological and physical stress-induced cardiovascular reactivity and diurnal blood pressure variation in women with different work shifts. Hypertens Res. 2002;25(4):543-551.
3. Kario K, James GD, Marion R, Ahmed M, Pickering TG. The infuence of work- and home-related stress on the levels and diurnal variation of ambulatory blood pressure and neurohumoral factors in employed women. Hypertens Res. 2002;25(4):499-506.
4. Kawasaki T, Cugini P, Uezono K, et al. Circadian variations of total renin, active renin, plasma renin activity and plasma aldosterone in clinically healthy young subjects. Horm Metab Res. 1990;22(12):636-639.
5. Muller JE, Tofer GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79(4):733-743.
6. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke. 1989;20(4):473-476.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
8. Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis D P. Uric acid and diabetes: is there a link? Curr Pharm Des. Epub December 26, 2012.
9. Cohen E, Krause I, Fraser A, Goldberg E, Garty M. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J. 2012;14(11):676-680.
10. Borges RL, Ribeiro AB, Zanella MT, Batista MC. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep. 2010;12(2):113-119.
11. Jalal DI, Chonchol M, Chen W, Targher G. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013;61(1):134-146.
12. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
13. White WB, Larocca GM. Improving the utility of the nocturnal hypertension defnition by using absolute sleep blood pressure rather than the "dipping" proportion. Am J Cardiol. 2003;92(21):1439-1441.
14. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10): 1401-1406.
15. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004;28(3):402-409.
16. Kaplan NM. Kaplan's Clinical Hypertension, 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
17. Wasada T, Katsumori K, Saeki A, Iwatani M. [Hyperuricemia and insulin resistance]. Nippon Rinsho. 1996;54(12):3293-3296. Japanese.
18. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism. 2007;56(6):751-756.
19. Korpachev V V, Hurina NM, Korpacheva TI, Shuprovych AA, Mosendz IO. [Peculiarities of uric acid balance disorders in patients with type 2 diabetes and metabolic syndrome.] Fiziol Zh. 2009:55(3):133-140. Ukrainian.
20. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996;19(5):414-418.
21. Yo o T W, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928-933.
22. Onat A, Uyarel H, Hergenç G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 2006:19(10):1055-1062.
23. See LC, Kuo C F, Chuang FH, et al. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular fltration rate. J Rheumatol. 2009;36(8): 1691-1698.
24. Quiñones Galvan A, Natali A, Baldi S, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol. 1995;268(1 Pt 1):E1-E5.
25. Kario K, Pickering TG, Hoshide S, et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens. 2004;17(8): 668-675.
26. Otto ME, Svatikova A, Barretto RB, et al. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109(21): 2507-2510.
27. Hall JE, Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994;23(3): 381-394.
28. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sym-pathoadrenal system. N Engl J Med. 1996;334(6):374-381.
29. Rocchini A P, Katch V, Kveselis D, et al. Insulin and renal sodium retention in obese adolescents. Hypertension. 1989;14(4):367-374.
30. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996; 97(11):2601-2610.
31. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(4):28-33.
32. Zoppini G, Targher G, Negri C, et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care. 2009;32(9):1716-1720.
33. Kim SY, Guevara J P, Kim KM, Choi HK, Heitjan D F, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885-892.
34. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009;266(6):558-570.